Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:27 AM
Ignite Modification Date:
2025-12-25 @ 3:27 AM
NCT ID:
NCT01522105
Eligibility Criteria:
Inclusion Criteria:
* Age \> 3 months and \< 16 years
* Bacterial meningitis
* Written parental (or appropriate legal representative) informed consent prior to study inclusion
Exclusion Criteria
* Gram-negative bacteria in the CSF
* Creatinine clearance \< 80ml/min/1.73m2
* Creatinine phosphokinase level \> 2x upper age related norm
* Known allergy or hypersensitivity to daptomycin
* Known clinical significant cardiovascular, pulmonary, renal, hepatic, gastrointestinal, endocrine, hematologic, autoimmune disease, or primary immunodeficiency
* Height and weight below 3rd or above 95th percentile
* History of, or current muscular disease
* Underlying neurological disease with disruption of blood brain barrier
* Epilepsy
* Muscular weakness, history of peripheral neuropathy, or Guillain-Barré syndrome
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
3 Months
Maximum Age:
16 Years
Study:
NCT01522105
Study Brief:
Protocol Section:
NCT01522105